These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33740211)

  • 1. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
    Hepatol Int; 2021 Apr; 15(2):413-423. PubMed ID: 33740211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.
    Baratta F; Pastori D; Angelico F; Balla A; Paganini AM; Cocomello N; Ferro D; Violi F; Sanyal AJ; Del Ben M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2324-2331.e4. PubMed ID: 31887443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.
    Lee J; Kim HS; Cho YK; Kim EH; Lee MJ; Bae IY; Jung CH; Park JY; Kim HK; Lee WJ
    Sci Rep; 2020 Oct; 10(1):18323. PubMed ID: 33110139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
    Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores.
    Tsai TY; Hsu PF; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Lu TM; Leu HB
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Lu C; Chen Y; Zhang Y; Zhao X
    Diabetes Metab Syndr Obes; 2023; 16():2627-2637. PubMed ID: 37663203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.
    Hsiao CC; Teng PH; Wu YJ; Shen YW; Mar GY; Wu FZ
    BMC Cardiovasc Disord; 2021 May; 21(1):244. PubMed ID: 34011282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation.
    Chen LZ; Jing XB; Wu CF; Zeng YC; Xie YC; Wang MQ; Chen WX; Hu X; Zhou YN; Cai XB
    Dis Markers; 2021; 2021():6591784. PubMed ID: 34992694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation.
    Tan SH; Zhou XL
    Clinics (Sao Paulo); 2023; 78():100301. PubMed ID: 37952443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
    Song DS; Chang UI; Kang SG; Song SW; Yang JM
    Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.
    McNally BB; Rangan P; Wijarnpreecha K; Fallon MB
    Dig Dis Sci; 2023 Sep; 68(9):3765-3773. PubMed ID: 37392337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
    Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    Friedrich-Rust M; Schoelzel F; Maier S; Seeger F; Rey J; Fichtlscherer S; Herrmann E; Zeuzem S; Bojunga J
    PLoS One; 2017; 12(10):e0186720. PubMed ID: 29073252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver disease.
    Ishiba H; Sumida Y; Kataoka S; Kuroda M; Akabame S; Tomiyasu K; Tanaka M; Arai M; Taketani H; Seko Y; Okajima A; Hara T; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Itoh Y
    Hepatol Res; 2016 Oct; 46(11):1107-1117. PubMed ID: 26853695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
    Önnerhag K; Hartman H; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study.
    Zhang HW; Jin JL; Cao YX; Liu HH; Zhang Y; Guo YL; Wu NQ; Zhu CG; Gao Y; Xu RX; Hua Q; Li YF; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
    Ann Transl Med; 2020 Nov; 8(21):1349. PubMed ID: 33313094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study.
    Zhang Y; Jin JL; Cao YX; Liu HH; Zhang HW; Guo YL; Wu NQ; Gao Y; Hua Q; Li YF; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
    J Transl Med; 2020 Oct; 18(1):373. PubMed ID: 33004038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.